USDCAD has fallen a sizable 4% since our last publication, but this is reflective entirely of the broad dollar’s anti-cyclical properties and negative beta to risk, and is not indicative of outright CAD outperformance. CAD headwinds bias our USDCAD forecasts higher over the medium-term. In some ways, that CAD has only depreciated 2.2% on net against the dollar since March despite the intervening pandemic-led global recession, Saudi-Russo price war, briefly-negative oil prices, and the single greatest Canadian economic & labor market shock ever is remarkable. But this is indicative more of the recent market paradigm shift around risky markets and the USD which has whole-heartedly embraced of the reopening of global economies and the attendant bounce-back in growth, despite the fact that global benchmark oil levels are still 25-30% below pre-crisis levels and US & Canadian unemployment could remain above 10% of the remainder of the year. Indeed, despite USDCAD touching 1.33 and dropping 6.5% total since mid-March, CAD is unexceptional when compared against other G10 currencies this month and, against pre-COVID levels, CAD is actually a relative laggard in G10 (refer above chart).
Thus, despite recent USDCAD weakness, we continue to harbor reservations about the prospects of CAD’s resilience this year, but believe this pessimism is better expressed tactically through crosses than versus the USD as the latter continues to consolidate in the pro-growth environment and as CAD remains well-correlated with riskier assets.
Trading tips: At spot reference: 1.3653 levels (while articulating), one-touch call options strategy is advocated using upper strikes at 1.38 levels. One can see exponential yields as the underlying spot FX keeps spiking towards upper strike on the expiration.
Alternatively, we recommended directional hedges that comprised of longs in USDCAD futures contracts of July’20 delivery, simultaneously, shorts in futures of June’20 delivery. The short leg has delivered desirable hedging objectives so far due to the price dips in the recent past. While long leg of July tenor should be upheld with an objective of arresting potential bullish risks.


NHS shakeup: if it sounds like we’ve been here before, it’s because we have
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
Goldman Sachs Sees Stronger U.S. Dollar as Global Economic Gaps Widen
Asian Currencies Steady as U.S.-Iran Ceasefire Extension Hopes Weigh on Dollar
Gold Cracks Below $4,500 as Safe-Haven Shine Fades; Technical Breakdown Signals Sell-on-Rallies Toward $4,000
Cuba needs a long-term solution to its energy crisis
2025 Market Outlook: Key January Events to Watch
US Futures Rise as Investors Eye Earnings, Inflation Data, and Wildfire Impacts
Global Markets React to Strong U.S. Jobs Data and Rising Yields
US Dollar Slips as Markets Weigh Potential US-Iran Peace Deal and Oil Price Outlook
Gold Prices Fall Amid Rate Jitters; Copper Steady as China Stimulus Eyed
Rice feeds billions of people – but its role in fueling climate change is growing
Oil Prices Dip Slightly Amid Focus on Russian Sanctions and U.S. Inflation Data
Geopolitical Shocks That Could Reshape Financial Markets in 2025 



